Company intelligence / Profile preview
Argent BioPharma
Subiaco, Western AU, Australiaargentbiopharma.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Argent BioPharma is a clinical-stage biopharmaceutical company leveraging polypharmacology and nanotechnology to develop innovative therapies for CNS and autoimmune disorders. Its lead program CannEpil®, a high-CBD oral solution for refractory epilepsy, is available in early access schemes in the UK and has shown promise in reducing seizure frequency. Other assets target acute lung injury/ARDS, dementia/Alzheimer’s disease, glioblastoma multiforme, and chronic wounds. The company operates globally with clinical activity in Europe, Australia, the UK, and the US.
- Therapeutic areas
- PulmonologyOncologyNeurologyInfectious Diseases
- Modalities
- Small molecules (notably cannabinoid-based therapies)Nanotechnology-enabled drug delivery
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
SINTEF collaboration for antimicrobial/chronic wound researchPartnership with I AM Billy Foundation for UK patient access to CannEpil
Beyond the preview
Go deeper on Argent BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Argent BioPharma.